IBDEI04S ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5884,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5884,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,5884,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,5885,0)
 ;;=L23.7^^26^391^30
 ;;^UTILITY(U,$J,358.3,5885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5885,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,5885,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,5885,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,5886,0)
 ;;=L23.9^^26^391^31
 ;;^UTILITY(U,$J,358.3,5886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5886,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5886,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,5886,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,5887,0)
 ;;=L24.9^^26^391^163
 ;;^UTILITY(U,$J,358.3,5887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5887,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5887,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,5887,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,5888,0)
 ;;=L25.9^^26^391^115
 ;;^UTILITY(U,$J,358.3,5888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5888,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5888,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,5888,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,5889,0)
 ;;=L26.^^26^391^148
 ;;^UTILITY(U,$J,358.3,5889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5889,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,5889,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,5889,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,5890,0)
 ;;=L27.0^^26^391^265
 ;;^UTILITY(U,$J,358.3,5890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5890,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,5890,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,5890,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,5891,0)
 ;;=L27.1^^26^391^266
 ;;^UTILITY(U,$J,358.3,5891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5891,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,5891,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,5891,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,5892,0)
 ;;=L29.0^^26^391^250
 ;;^UTILITY(U,$J,358.3,5892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5892,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,5892,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,5892,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,5893,0)
 ;;=L29.9^^26^391^251
 ;;^UTILITY(U,$J,358.3,5893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5893,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,5893,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,5893,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,5894,0)
 ;;=L30.0^^26^391^232
 ;;^UTILITY(U,$J,358.3,5894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5894,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,5894,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,5894,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,5895,0)
 ;;=L30.1^^26^391^140
 ;;^UTILITY(U,$J,358.3,5895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5895,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,5895,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,5895,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,5896,0)
 ;;=L30.2^^26^391^132
 ;;^UTILITY(U,$J,358.3,5896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5896,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,5896,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,5896,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,5897,0)
 ;;=L30.4^^26^391^144
 ;;^UTILITY(U,$J,358.3,5897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5897,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,5897,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,5897,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,5898,0)
 ;;=L30.8^^26^391^135
 ;;^UTILITY(U,$J,358.3,5898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5898,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,5898,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,5898,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,5899,0)
 ;;=L30.9^^26^391^136
 ;;^UTILITY(U,$J,358.3,5899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5899,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,5899,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,5899,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,5900,0)
 ;;=L40.0^^26^391^253
 ;;^UTILITY(U,$J,358.3,5900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5900,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,5900,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,5900,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,5901,0)
 ;;=L40.1^^26^391^256
 ;;^UTILITY(U,$J,358.3,5901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5901,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,5901,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,5901,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,5902,0)
 ;;=L40.2^^26^391^11
 ;;^UTILITY(U,$J,358.3,5902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5902,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,5902,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,5902,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,5903,0)
 ;;=L40.3^^26^391^255
 ;;^UTILITY(U,$J,358.3,5903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5903,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,5903,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,5903,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,5904,0)
 ;;=L40.4^^26^391^157
 ;;^UTILITY(U,$J,358.3,5904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5904,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,5904,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,5904,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,5905,0)
 ;;=L40.8^^26^391^252
 ;;^UTILITY(U,$J,358.3,5905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5905,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,5905,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,5905,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,5906,0)
 ;;=L40.9^^26^391^254
 ;;^UTILITY(U,$J,358.3,5906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5906,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,5906,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,5906,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,5907,0)
 ;;=L50.9^^26^391^286
 ;;^UTILITY(U,$J,358.3,5907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5907,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,5907,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,5907,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,5908,0)
 ;;=L53.8^^26^391^147
 ;;^UTILITY(U,$J,358.3,5908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5908,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,5908,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,5908,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,5909,0)
 ;;=L53.9^^26^391^146
 ;;^UTILITY(U,$J,358.3,5909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5909,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,5909,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,5909,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,5910,0)
 ;;=L54.^^26^391^145
 ;;^UTILITY(U,$J,358.3,5910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5910,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,5910,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,5910,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,5911,0)
 ;;=L56.0^^26^391^139
 ;;^UTILITY(U,$J,358.3,5911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5911,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,5911,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,5911,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,5912,0)
 ;;=L56.1^^26^391^138
 ;;^UTILITY(U,$J,358.3,5912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5912,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,5912,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,5912,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,5913,0)
 ;;=L56.2^^26^391^236
 ;;^UTILITY(U,$J,358.3,5913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5913,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,5913,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,5913,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,5914,0)
 ;;=L56.3^^26^391^268
 ;;^UTILITY(U,$J,358.3,5914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5914,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,5914,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,5914,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,5915,0)
 ;;=L57.0^^26^391^12
 ;;^UTILITY(U,$J,358.3,5915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5915,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,5915,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,5915,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,5916,0)
 ;;=L60.0^^26^391^161
 ;;^UTILITY(U,$J,358.3,5916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5916,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,5916,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,5916,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,5917,0)
 ;;=L60.1^^26^391^234
 ;;^UTILITY(U,$J,358.3,5917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5917,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,5917,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,5917,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,5918,0)
 ;;=L60.2^^26^391^233
 ;;^UTILITY(U,$J,358.3,5918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5918,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,5918,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,5918,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,5919,0)
 ;;=L60.3^^26^391^170
 ;;^UTILITY(U,$J,358.3,5919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5919,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,5919,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,5919,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,5920,0)
 ;;=L60.4^^26^391^88
 ;;^UTILITY(U,$J,358.3,5920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5920,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,5920,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,5920,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,5921,0)
 ;;=L60.5^^26^391^290
 ;;^UTILITY(U,$J,358.3,5921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5921,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,5921,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,5921,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,5922,0)
 ;;=L60.8^^26^391^168
